文献速递细菌感染、耐药与抗菌药物艾滋病与性传播感染

近期阿奇霉素暴露与淋球菌敏感性下降相关

Decreased Azithromycin Susceptibility of Neisseria gonorrhoeae Isolates in Patients Recently Treated with Azithromycin.
PubMed 文献 · Clin Infect Dis · 2017-01-01

该研究纳入1999至2013年阿姆斯特丹STI诊所323株淋球菌,分析此前60天内阿奇霉素处方暴露与MIC的关联。校正年龄、种族、感染部位和年份后,≤30天暴露与MIC显著相关(β=1.00,95%CI 0.44-1.56,P=.002)。全基因组测序提示暴露与mtrR A39T或G45D突变相关(P=.046)。

要点

  • 近期(≤30天)阿奇霉素暴露与淋球菌阿奇霉素MIC升高独立相关。
  • 暴露与mtrR A39T或G45D突变相关,提示耐药机制。
  • 高危人群中频繁使用阿奇霉素可能诱导淋球菌耐药。

核心结论

  • 近期阿奇霉素暴露与淋球菌阿奇霉素MIC升高显著相关,可能诱导耐药。

研究设计与样本

  • 回顾性分析1999至2013年阿姆斯特丹STI诊所323株淋球菌,暴露定义为前次就诊(60天内)阿奇霉素处方。

主要发现

  • 共323株,212株未暴露,14株≤30天暴露,97株31-60天暴露。
  • 平均阿奇霉素MIC为0.28 mg/L(范围<0.016-24 mg/L)。
  • 校正年龄、种族、感染部位和年份后,≤30天暴露与MIC显著相关(β=1.00,95%CI 0.44-1.56,P=.002)。
  • 31株行WGS,暴露与mtrR A39T或G45D突变显著相关(P=.046),与MLST或NG-MAST型别无关。

临床怎么用

  • 在高淋球菌感染风险人群中应审慎使用阿奇霉素,以减缓MIC升高和耐药发生。

局限性

  • 原文未明确报告研究设计类型及除WGS亚组外的其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Increasing azithromycin usage and resistance in Neisseria gonorrhoeae threatens current dual treatment. Because antimicrobial exposure influences resistance, we analyzed the association between azithromycin exposure and decreased susceptibility of N. gonorrhoeae. METHODS: We included N. gonorrhoeae isolates of patients who visited the Amsterdam STI Clinic between 1999 and 2013 (t0), with another clinic visit in the previous 60 days (t-1). Exposure was defined as the prescription of azithromycin at t-1. Using multivariable linear regression, we assessed the association between exposure and azithromycin minimum inhibitory concentration (MIC). Whole genome sequencing (WGS) was performed to produce a phylogeny and identify multilocus sequence types (MLST), N. gonorrhoeae multiantigen sequence types (NG-MAST), and molecular markers of azithromycin resistance. RESULTS: We included 323 isolates; 212 were unexposed to azithromycin, 14 were exposed ≤30 days, and 97 were exposed between 31 and 60 days before isolation. Mean azithromycin MIC was 0.28 mg/L (range, <0.016-24 mg/L). Linear regression adjusted for age, ethnicity, infection site, and calendar year showed a significant association between azithromycin exposure ≤30 days and MIC (β, 1.00; 95% confidence interval, 0.44-1.56; P = .002). WGS was performed on 31 isolates: 14 unexposed, 14 exposed to azithromycin ≤30 days before isolation, and 3 t-1 isolates. Exposure to azithromycin was significantly associated with A39T or G45D mtrR mutations (P = .046) but not with MLST or NG-MAST types. CONCLUSIONS: The results suggest that frequent azithromycin use in populations at high risk of contracting N. gonorrhoeae induces an increase in MIC and may result in resistance.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Wind CM, de Vries E, Schim van der Loeff MF, et al. Decreased Azithromycin Susceptibility of Neisseria gonorrhoeae Isolates in Patients Recently Treated with Azithromycin. Clin Infect Dis. 2017. PMID: 28510723. doi:10.1093/cid/cix249

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。